Alfresa Holdings ( (JP:2784) ) just unveiled an update.
Alfresa Holdings Corporation announced its decision to cancel 11,540,000 of its treasury shares, representing 5.7% of its outstanding shares, as part of a strategic move to optimize its capital structure. This cancellation, set to occur on March 14, 2025, is expected to impact the company’s share value and market positioning positively.
More about Alfresa Holdings
The Alfresa Group is a leader in the Japanese healthcare industry, focusing on ethical pharmaceuticals wholesaling, OTC pharmaceuticals wholesaling, pharmaceutical manufacturing, and operating dispensing pharmacies. The company reported a consolidated revenue of ¥2.8 trillion for the fiscal year ended March 31, 2024.
YTD Price Performance: -3.61%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.66B
Learn more about 2784 stock on TipRanks’ Stock Analysis page.